Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Japanese Medtech Startup, CoreTissue BioEngineering, Initiates Randomized Controlled Cohort in the Clinical Trial for Anterior Cruciate Ligament (ACL) Reconstruction Treatment

Summary by WBOC 16
CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture,

2 Articles

WBOC 16WBOC 16
Reposted by
mykxlg.commykxlg.com
Center

Japanese Medtech Startup, CoreTissue BioEngineering, Initiates Randomized Controlled Cohort in the Clinical Trial for Anterior Cruciate Ligament (ACL) Reconstruction Treatment

CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture,

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WBOC 16 broke the news on Monday, May 11, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Kanagawa Prefecture icon

Kanagawa Prefecture

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal